With advances in cancer genomics, a group of genes has been identified as drivers of LUAD, including mutations in the epidermal growth factor receptor (EGFR), c-MET, KRAS, and anaplastic lymphoma kinase (ALK) [3]. Here, EGFR is linked to cancer.